MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Patient perspectives of using the ND0612 mini-pump

    S. Nash, M. Gera, E. Shor, T. Rachmilewitz Minei, S. Oren (Rehovot, Israel)

    Objective: To evaluate patient and caregiver usability and satisfaction with the mini-pump that will be used for continuous ND0612 delivery among patients with moderate-severe PD.…
  • 2017 International Congress

    Five year longitudinal change in the MDS-UPDRS scores in early Parkinson’s disease participants: Results from the PPMI Study

    T. Simuni, C. Caspell-Garcia, N. Seedorff, C. Coffey, S. Lasch, B. Mollenhauer, C. Tanner, K. Kieburtz, K. Marek (Chicago, IL, USA)

    Objective: To determine the longitudinal change in the Movement Disorder Society –Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) in Parkinson’s disease (PD) participants who were untreated…
  • 2017 International Congress

    Tremor’s Glove – An Innovative Electrical Muscle Stimulation Therapy to Treat Intractable Tremor in Parkinson’s Disease Patients: A Randomized Sham-Controlled Trial

    O. Jitkritsadakul, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To investigate the efficacy of a novel EMS device (Tremor’s glove) for reducing intractable resting hand tremor in PD. Background: Intractable resting hand tremor is…
  • 2017 International Congress

    Tozadenant phase 3 study (TOZ-PD) in Parkinson’s disease patients with motor fluctuations: baseline characteristics

    K. Kieburtz, W. Olanow, J. Krishnaswami, C. Resburg, F. Kerwood, C. Kenney (Rochester, NY, USA)

    Objective: To describe the baseline characteristics of the TOZ-PD study population. Background: Tozadenant is an adenosine A2A antagonist under investigation as an adjunct to levodopa…
  • 2017 International Congress

    Impaired sensorimotor and visual networks in drug naive Parkinson’s disease based on graph theoretical analysis

    H. Chen (Beijing, China)

    Objective: We aim to investigate topographic structure in drug naive patients with Parkinson’s disease (PD). Background: Resting state functional magnetic resonance imaging (rs-fMRI) provides valuable…
  • 2017 International Congress

    99mTc-TRODAT-1 SPECT imaging in early and late onset Parkinson’s disease.

    A. Ghabeli Juibary, V.R. Dabbagh Kakhki, P. Sasannejad, R. Sadeghi, K. Sadri, M. Sabour, H. Alizadeh (Mashhad, Islamic Republic of Iran)

    Objective: In this study we tried to determine  the TRODAT SPECT findings in EOPD  as compared to LOPD. Background: 99mTc-TRODAT-1, which binds to the dopamine…
  • 2017 International Congress

    Writing training enhances neural connectivity in Parkinson’s patients with micrographia

    E. Nackaerts, J. Michely, E. Heremans, S. Swinnen, B. Smits-Engelsmans, W. Vandenberghe, C. Grefkes, A. Nieuwboer (Leuven, Belgium)

    Objective: To study network interactions of patients with Parkinson’s disease (PD) and healthy controls (CT) during handwriting with and without external visual cues and to…
  • 2017 International Congress

    Action Observation Training Effects on Brain Structural and Functional Changes in Parkinson’s Disease Patients

    E. Sarasso, F. Agosta, M. Di Meo, M. Giacobbe, M.A. Volonté, G. Comi, A. Tettamanti, R. Gatti, M. Filippi (Milan, Italy)

    Objective: To assess brain functional and structural changes following action observation training (AOT) associated with exercises of balance, gait, transfers and manual dexterity in Parkinson’s…
  • 2017 International Congress

    Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease – on behalf of Critical Path for Parkinson’s (CPP) Consortium

    D. Stephenson, J. Cedarbaum, J. Eberling, M. Facheris, D. Grosset, M. Gordon, D. Hill, S. Imam, V. Kern, G. Klein, D. Matthews, P. Muglia, A. Roach, K. Romero, D. Russell, J. Seibyl, L. Slieker, E. Somer, C. Sur, Z. Xie, K. Marek (Tucson, AZ, USA)

    Objective: A key goal of the Critical Path for Parkinson’s Consortium (CPP) is to qualify, with regulatory agencies, drug development tools for use in PD…
  • 2017 International Congress

    Sleep disturbance may alter white matter and resting state functional connectivities in Parkinson’s disease

    S.J. Chung, Y.-H. Choi, H. Kwon, Y.-H. Park, H.J. Yun, H.S. Yoo, Y.H. Sohn, J.-M. Lee, P.H. Lee (Seoul, Republic of Korea)

    Objective: To clarify whether sleep disturbance would alter the patterns of structural and functional networks underlying cognitive dysfunction in patients with Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley